J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP From US FDA

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1735.2000 0.80 (0.05%)

NSE Jun 16, 2025 15:31 PM

25.22% Gain from 52W Low

Volume: 80,114

J B Chemicals & Pharmaceuticals Ltd.

23 Aug 2023

1735.20

0.05%

Company Update

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP …

BSE India

Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA

More from J B Chemicals & Pharmaceuticals Ltd.

Recommended

Chart of the Week: FIIs raise bets in consumer-driven sectors over the year

The Baseline | 16 Jun 2025, 05:21PM

IPOs This Week: Oswal Pumps and Three Others to List; Arisinfra Plus Five New Issues

| 16 Jun 2025, 05:10PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23